Literature DB >> 23553049

Disposition of ceftriaxone in hepatopathic goats following single-intramuscular dosing.

Tapas Kumar Sar1, Tapan Kumar Mandal, Pabitra Hriday Patra, Indranil Samanta.   

Abstract

Hepatopathy sometimes may interfere with metabolism and/or elimination of drugs which undergo major hepatic clearance. Twelve healthy goats were equally divided into two groups (I and II) and hepatopathy was induced by carbontetrachloride in the second group (group II). A single dose of ceftriaxone at 50 mg/kg was administered to each group intramuscularly. Disposition of ceftriaxone in plasma of healthy goats showed a typical absorption-reabsorption phase. However, the reabsorption phase was totally absent in hepatopathic goats and the disposition of ceftriaxone showed only absorption and distribution/elimination phase. The drug persisted in plasma for 6 h in hepatopathic animals, whereas the drug can only be detected up to 2 h in healthy animals indicating longer persistence of ceftriaxone in the former group. Ceftizoxime, the active metabolite of ceftriaxone was available in urine of group I animals, whereas only ceftriaxone was detected in the urine of hepatopathic animals suggesting impairment of metabolism of the parent drug in hepatopathy. Therefore, the reabsorption and metabolism of ceftriaxone in goats should be taken into consideration for drug monitoring.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553049     DOI: 10.1007/s13318-013-0129-x

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Plasma pharmacokinetics and milk levels of ceftriaxone following single intravenous administration in healthy and endometritic cows.

Authors:  Sudershan Kumar; Anil K Srivastava; V K Dumka; Naresh Kumar; Rajinder K Raina
Journal:  Vet Res Commun       Date:  2010-06-24       Impact factor: 2.459

2.  Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats.

Authors:  M M Ismail
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2005-09

3.  Pharmacokinetic interaction of intramammary ceftriaxone and oral polyherbal drug (Fibrosin(®)) in goats.

Authors:  Tapas Kumar Sar; Pabitra Hriday Patra; Jeevan Ranjan Dash; Tapan Kumar Mandal
Journal:  Drug Metabol Drug Interact       Date:  2011-11-19

4.  Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camels (Camelus Dromedarius).

Authors:  A Goudah
Journal:  Res Vet Sci       Date:  2007-09-04       Impact factor: 2.534

Review 5.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

6.  Disposition kinetics of sparfloxacin in healthy, hepatopathic, and nephropathic conditions in chicken after single intravenous administration.

Authors:  M K Bhar; S Khargharia; A K Chakraborty; T K Mandal
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

7.  Pharmacokinetics of ceftriaxone in carbontetrachloride-induced hepatopathic and uranyl nitrate-induced nephropathic goats following single dose intravenous administration.

Authors:  Tapas Kumar Sar; Tapan Kumar Mandal; Shymal Kumar Das; Animesh Kumar Chakraborty
Journal:  Drug Metab Lett       Date:  2008-01

8.  Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.

Authors:  G A Albarellos; V E Kreil; M F Landoni
Journal:  J Vet Pharmacol Ther       Date:  2007-08       Impact factor: 1.786

9.  Hepatic granulomas: histological and molecular pathological approach to differential diagnosis--a study of 442 cases.

Authors:  Uta Drebber; Hans-Udo Kasper; Judith Ratering; Inga Wedemeyer; Peter Schirmacher; Hans-Peter Dienes; Margarete Odenthal
Journal:  Liver Int       Date:  2008-07       Impact factor: 5.828

  9 in total
  2 in total

1.  Disulfiram-like Reaction Involving Ceftriaxone in a Pediatric Patient.

Authors:  Stephen M Small; Rachel S Bacher; Sheridan A Jost
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

2.  Potential of a polyherbal drug to prevent antimicrobial resistance in bacteria to antibiotics.

Authors:  Tapas Kumar Sar; Indranil Samanta; Achintya Mahanti; Shabnam Akhtar; Jeevan Ranjan Dash
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.